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Abstract
Background: The study was planned to assess effect of physical exercise on bone remodeling in type I diabetics
with osteopenia.
Methods: Twenty-four type I diabetes mellitus (DM1) with osteopenia (10 females and 14 males) were compared
to thirty-eight age- and sex-matched healthy control individuals (20 females and 18 males) for biochemical and
radiologic parameters of bone mass. Laboratory investigations included serum and urinary calcium, inorganic
phosphorus, alkaline phosphatase, and serum “procollagen type 1 N-terminal propeptide (P1NP). Bone
densitometry was assessed at neck femur using Dual Energy X-ray Absorptiometry (DEXA). Serum P1NP and DEXA
were reevaluated after a planned exercise program.
Results: Patients and controls were comparable with respect to serum as well as urinary biochemical parameters
of bone mass namely; calcium, phosphorus and total serum alkaline phosphatase. Osteopenic DM1 patients
displayed lower mean serum P1NP than control group (20.11 ± 6.72 ug\dL versus 64.96 ± 34.89 ug\dL; p < 0.05). A
significant correlation was observed between BMD and degree of glycemic control reflected by serum glycated
hemoglobin (r = -0.44, p, 0.030). Bone densitometry correlated with serum P1NP (r = -0.508, p, 0.011). After a
planned regular exercise for 3 months, serum P1NP and BMD levels increased with percentage change of 40.88 ±
31.73 and 3.36 ± 2.94, respectively. Five patients resumed normal densitometry and they were all males.
Conclusion: Diabetic osteopenic patients displayed lower serum levels of procollagen type 1 N-terminal
propeptide which reflects poor bone formation. A 3-months planned exercise program was associated with
improvement of bone densitometry and significant increment of serum P1NP.
Background
Osteopenia is not uncommon in children and adoles-
cents with DM1 [1]. The mechanism by which the bone
loss occurs in diabetic patients could be explained by a
reduction of insulin\insulin like growth factor 1 action,
sustained hyperglycemic state, generation of glycosyla-
tion end–products, and diabetic complications such as
neuropathy, nephropathy, and retinopathy. Osteoblast
deficit is suggested to play important role in the occur-
r e n c eo fd i a b e t i co s t e o p e n i a[ 2 ] .B o n ef o r m a t i o na t
onset of DM1 is not impaired. The introduction of insu-
lin therapy together with the achievement of a good
metabolic control determine an increase of bone matrix
formation coupled with a decrease of bone resorption,
which determine a positive balance of bone remodeling
[3]. Giannini et al. [4] stated that exercise seems to be
very effective in reducing the side effects of the disease,
providing three major benefits for exercise; it reduces
the diabetic needs for insulin, reduces platelets adhesive-
ness, and reduces severity of risk factors of coronary
artery disease (hypertension, obesity, blood lipids, and
serum uric acid). Special considerations are needed for
physically active individuals with type 1 diabetes melli-
tus. Although regular activity is beneficial for all
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in blood glucose. The glycemic response depends largely
on the type, intensity and duration of the activity, circu-
lating insulin and glucose counter regulatory hormone
concentrations, type and timing of food, metabolic con-
trol, muscle mass/number of muscles used in activity,
conditioning, and Degree of stress/competition involved
in the activity and timing of activity [5-7]. The current
prospective study was planned to assess bone remodel-
ing status in osteopenic DM1 patients and its relation to
diabetes duration and glycemic control, and the effect of
planned physical exercise on bone mass.
Materials and methods
Subjects
We studied 24 pubertal and adolescent patients with
DM1; 10 females and 14 males whose ages’ range was 14-
20 years. They were regularly attending Outpatients’ Dia-
betes Specialized Clinic, of Children’s Hospital, Ain Shams
University, Cairo, Egypt. Patients were compared to age-
(14-20 years) and gender-matched (20 females and 18
males) healthy control subjects. Exclusion criteria were
presence of diabetic complications, celiac disease, liver dis-
ease, presence of any associated musculoskeletal or meta-
bolic bone diseases, any chronic illness other than
diabetes, any medications other than insulin, and delayed
puberty. The study plan has been approved by local ethical
committee with a federal number: FWA00006444.
Methods
All patients were subjected to full history taking includ-
ing age at onset of the disease, duration of diabetes, pre-
s e n c eo fd i a b e t i cc o m p l i c a t i o n s ,p r e s e n c eo fa n y
musculoskeletal disease and history about regular exer-
cise or medications other than insulin. Full clinical
examination was performed with special stress on
growth parameters (weight, height, and pubertal stage),
blood pressure measurement and fundus examination.
Laboratory investigation
Fasting morning blood samples were drawn for determi-
nations of biochemical parameters. Serum and urinary
levels of calcium, inorganic phosphorous and serum
total alkaline phosphatase were measured by standard
laboratory techniques on Hitachi 747. Plasma HbA1c
was determined by an ion-exchange high performance
liquid chromatography. Nephropathy was excluded by
measuring microalbuminurea in relation to creatinine
clearance (Synchrony CX5 system) on 2 occasions one
month apart. Serum procollagen type 1 N-terminal pro-
peptide (P1NP) was estimated using rapid equilibrium
radioimmunoassay [8] (commercial antisera specifically
directed against the amino-terminal propeptide supplied
by Orion Diagnostica, Espoo, Finland) before and after
exercise program.
Bone densitometry Bone mineral density at left neck of
femur was measured by dual-energy X-ray absorptiome-
try (DEXA) using Hologic QDR 1000/W scanner, Wal-
tham, MA, USA) at study entry and repeated after an
exercise program. Results are expressed as BMD (g/
cm2). Low BMD was defined according to T-scores, cal-
culated on the basis of the normal reference values. The
T scores are reported as the number of standard devia-
tions below the young adult mean (normal, > -1; osteo-
penia, -1 to -2.49; osteoporosis, -2.5) [9].
Exercise program
Diabetic patients were offered an aerobic exercise pro-
gram in diabetes specialized clinic, 3 times a week for 3
months. The schedule was as follows: 15 minutes warm-
ing up for abdominal and back muscles, five minutes
rest, then 20 minutes on ergo meter, ten minutes rest
and lastly 20 minutes on ergo meter with constant
speed and resistance. Eleven osteopenic DM1 patients
were able to regularly complete such exercise regimen.
Precautions to avoid hypoglycemia
For 2 weeks prior study, patients were prepared as fol-
lows to join exercise program; 1: exercise was offered at
least 4 hours from rapid acting insulin dose with a blood
glucose level above 150 mg/dl just prior exercise; 2: glu-
cose monitoring immediately after, 2, 6, and 12, 24 and
36 hours after exercise; 3: Adequate carbohydrate repla-
cement before, during, and after exercise (average 15-30
gm) if blood sugar is less than 100 mg/dl; and 4: reduc-
tion of pre-prandial rapid-acting insulin doses (10-25%).
Statistical analysis
This was performed with SPSS statistical software, ver-
sion 15. Statistical significance of difference between
variables was analyzed by student “t”, Mann-Whitney,
and Wilcoxon rank, and paired “t” tests. Relation
between variables was studied by correlation coefficient
“r” test. Percentage change in serum P1NP and BMD
post exercise was calculated (value after minus value
before, divided by value before, times 100). Values of p
< 0.05 were considered significant. All statistical tests
were two-tailed.
Results
Clinical parameters
Patients with DM1 were comparable to control subjects
for mean age (Z = 0.33, p = 0.742) gender distribution
(X
2= 0.708, p = 0.400), weight percentile (Z = 0.786, p =
0.432), and height percentile (Z = 0.546, p = 0.585) as
shown in table 1.
Biochemical markers
As for biochemical markers of bone remodeling, mean
levels of serum and urinary calcium, phosphorus and
alkaline phosphatase in DM1 patients were not
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patients displayed lower mean serum P1NP when com-
pared with controls, p = < 0.001 (table 1). A non signifi-
cant difference was noted in mean serum P1NP between
boys and girls whether in patients or controls (p = 0.051
and 0.09, respectively, data not shown). No correlation
was observed between serum P1NP and degree of glyce-
mic control as assessed by mean of last 4 glycated
hemoglobin concentrations (HbA1c) (r = -0.28, p =
0.18) as illustrated in table 2.
Bone densitometry
All included patients were osteopenic, hence, their mean
BMD was lower than age and sex matched healthy sub-
jects (p = 0.026). An inverse correlation was observed
between bone densitometry and glycated hemoglobin
(table 2). BMD correlated with serum P1NP (Figure 1).
Effect of exercise on bone mass
Eleven patients only (seven males) were able to com-
plete 3-months regular exercise and were eligible for
evaluation. It is noteworthy mentioning that none of
DM1 patients experienced severe or symptomatic hypo-
glycemic attack during or within 24 hours post exercise.
Table 3 shows the effect of exercise on bone densitome-
try and serum P1NP in diabetic patients. With respect
Table 1 Clinical and Biochemical parameters in diabetic patients and control subjects
Clinical parameters Controls (n = 38) Patients (n = 24)
Age (yr) 16.97 ± 1.88
(14-20)
17.17 ± 2.01
(14 - 20)
Duration (yr) ———————————————————— 7.5 ± 2.7
(4-14)
Weight percentile 30.43 ± 22.28
(3 - 60)
41.42 ± 28.17
(3-77)
Height percentile 31.43 ± 26.59
(3-75)
27.46 ± 26.51
(3-90)
Biochemical markers
Serum calcium (mg/dl) 9 ± 0.22
(8.8 - 9.4)
9.12 ± 0.19
(8.8 - 9.5)
Serum phosphorus (mg/dl) 3.7 ± 0.19
(3.5 - 4)
3.75 ± 0.28
(3.1 - 4.5)
Serum alkaline phosphatase (U/L) 190.86 ± 44.72
(153 - 273)
245.9 ± 137.23
(115 - 803)
Urinary calcium (mg/g creatinine) 181 ± 31.9
(132 - 222)
187.75 ± 38.9
(112 - 266)
Urinary phosphorus (mg/g creatinine) 680.9 ± 216.1
(375 - 943)
721.4 ± 179
(369 - 985)
Serum P1NP (ug/dl) 64.96 ± 34.89
(21.9 - 166.6)
20.11 ± 6.72
(11.5 - 33.9)*
Bone densitometry
Bone mineral density (g/cm2) 0.98 ± 0.12
(0.86-1.12)
0.87 ± 0.10
(0.70-1.13)*
Table 2 Correlation of serum P1NP and BMD before
exercise in diabetic patients.
Serum P1NP Bone mineral Density
Diabetes duration r = 0.244 r = -0.283
p = 0.25 p = 0.18
Weight percentile r = 0.231 r = 0.452
p = 0.182 p = 0.021*
Glycated hemoglobin r = -0.28 r = 0.444
p = 0.175 p = 0.03*
Bone mineral density r = 0.508
p = 0.011*
*Significant
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Figure 1 Correlation between serum P1NP and BMD (r = 0.508;
p = 0.011).
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after exercise and 5 male patients turned non osteope-
nic. Serum P1NP levels increased to levels still signifi-
cantly lower than control values (Figure 2).
Discussion
It is demonstrated that several years after the diagnosis
of clinical diabetes mellitus, children have decreased
lumbar bone mineral density compared to control group
or healthy children matched for age, height, sex and
pubertal status. This decrease in BMD was already pre-
sent in the patients less than two years after diagnosis of
DM1 suggesting that a defect in bone mass accretion
occurs quite early in the disease [10]. Twenty four pub-
ertal and adolescent diabetics with low BMD were
recruited before starting any drug therapy other than
insulin. BMD was measured at the femoral neck, as this
site has the greatest value in predicting both hip and
other osteoporotic fractures [11]. Biochemical measure-
ment of bone turnover was assessed in a trial to explain
osteopenia. Alterations of calcium and Vitamin D3 bal-
ance have also been implicated as contributing factors
of diabetic osteopenia by some authors. In the current
cohort, serum and urinary calcium and phosphorus con-
centrations were found to be normal in all patients and
mean levels were comparable to age- and sex-matched
control subjects, similar to findings reported by others
[12]. Serum total alkaline phosphatase (AP) is the most
widely used marker of bone metabolism due to the wide
availability of inexpensive and simple methods. Once
liver disease is ruled out, serum levels of total AP pro-
vide a good impression of the extent of new bone for-
mation and osteoblast activity [13,14]. We found that
serum levels of total AP were comparable to control
subjects. However, mean serum P1NP, the other marker
of new bone formation, was lower in our DM1 osteope-
nic patients. Aminoterminal propeptides of procollagen
1( P 1 N P )b e i n gg e n e r a t e df r o mn e w l ys y n t h e s i z e dc o l -
lagen, are considered quantitative measures of newly
formed type 1 collagen, the most abundant form of col-
lagen found in bone. Although type I collagen propep-
tides may also arise from other sources, most of the
non-skeletal tissues exhibit a slower turnover than bone,
and contribute very little to the circulating propeptide
pool [15]. Reduced osteoblast activity has been investi-
gated extensively in DM1 patients with osteopenia [16].
Table 3 Effect of exercise on bone mass in eleven diabetic patients
Before After Percentage Change p
Serum P1NP
(ug/dl)
22.32 ± 7.92
(11.5 - 33.9)
29.95 ± 8.59*
(17.9- 47.9)
40.88 ± 31.73
(5.9 ± 107.76)
0.003*
BMD g/cm2 0.89 ± 0.07
(0.79-0.99)
0.92 ± 0.07*
(0.80-1.01)
3.36 ± 2.94
(-0.2-8.78)
0.004*
*Significant
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Figure 2 Effect of exercise on individual values of BMD (a) and serum P1NP (b).
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rent work may be considered while explaining causes of
osteopenia in DM1.
Consequences of poor metabolic control and/or insu-
lin deficiency have been reported to account for
increased bone resorption and bone loss. Presence of
correlation between BMD and glycated hemoglobin in
the current study is in line with others’ finding of poor
metabolic control in diabetics with consequent bone
loss. The expected negative correlation between BMD
and diabetes duration that has been reported by others
[17,18] wan not proven in our cohort.
In the current study, 11 patients were able to com-
plete a planed exercise program for 3 months. Mechani-
cal loading provided is known to be an anabolic
stimulus for bone as mechanic-sensing apparatus in
bone directs osteogenesis to where it is most needed for
improving bone strength [19]. The most easily demon-
strated interaction between physical activities and bone
mass is the substantial bone loss that follows complete
immobilization. When designing an exercise program
for patients with osteoporosis, it should not be harmful
in terms of hypoglycemia, worsening complications, and
fractures. Precautions were taken to avoid symptomatic
hypoglycemia and were effective in our patients as none
reported any episode. When they were re-evaluated post
exercise, BMD improved in patients with a variable
degree and 5 out of 11 (45.5%) resumed normal BMD
for age, sex and height. This might be explained in part
by new bone formation [20] reflected by significant
increase in serum P1NP. Our finding is supported by
the study of Burke et al. [21]. The latter assessed the
relationship between exercise, diabetes, and bone meta-
bolism, and found that there is an alteration in the
mineral content of the femurs in diabetic animals than
controls, and that mineral content of diabetic animals
placed on exercise regimen revealed values closer to
controls’ levels.
In conclusion, DM1 osteopenic patients displayed
lower serum P1NP levels which reflect poor bone for-
mation. Meanwhile, biochemical markers of bone mass
reflected by serum and urinary values of calcium, phos-
phorus and serum alkaline phosphatase were all within
normal range. A 3-months planned exercise program
was associated with improvement of bone densitometry
and significant increment in serum P1NP.
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